Caption Management’s GeneDx Holdings WGS Stock Holding History

Caption Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.46M	Sell	69,500 -20,000	-22%	-$1.82M	0.03%	561
2025 Q4	$11.6M	Buy	89,500 +10,000	+13%	+$1.37M	0.08%	296
2025 Q3	$8.57M	Sell	79,500 -42,500	-35%	-$4.63M	0.07%	321
2025 Q2	$11.3M	Buy	+122,000	New	+$9.58M	0.12%	179
2025 Q1	–	Sell	-12,500	Closed	-$961K	–	2094
2024 Q4	$961K	Buy	+12,500	New	+$873K	0.01%	928

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caption Management's WGS Position: Q2 2022 in Review

Caption Management sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 25,994 shares — an estimated $2.63M sold.

Caption Management first reported a position in WGS in Q4 2021 and held it in 2 quarters. The position peaked at $2.63M in Q1 2022. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

Caption Management reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
Caption Management sold 25,994 GeneDx Holdings shares in Q2 2022, an estimated $2.63M.
Caption Management first reported a position in GeneDx Holdings in Q4 2021 and held it in 2 quarters.
Caption Management's GeneDx Holdings position peaked at $2.63M in Q1 2022.
111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Caption Management's 13F filing for Q2 2022, filed 15 Aug 2022.